img

Global Cancer Targeted Drug Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Cancer Targeted Drug Market Insights, Forecast to 2034

Targeted therapy is a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
Market Analysis and InsightsGlobal Cancer Targeted Drug Market
Global Cancer Targeted Drug market is expected to reach to US$ 56900 million in 2024, with a positive growth of %, compared with US$ 50220 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Cancer Targeted Drug industry is evaluated to reach US$ 97020 million in 2029. The CAGR will be 9.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Cancer Targeted Drug market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Cancer Targeted Drug market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Segment by Type
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other

Segment by Application


Hospital
Retail Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Cancer Targeted Drug introduction, etc. Cancer Targeted Drug Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Cancer Targeted Drug
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cancer Targeted Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Sorafenib
1.2.3 Lenvatinib
1.2.4 Regorafenib
1.2.5 Osimertinib
1.2.6 Anlotinib
1.2.7 Alectinib
1.2.8 Other
1.3 Market by Application
1.3.1 Global Cancer Targeted Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cancer Targeted Drug Market Perspective (2018-2029)
2.2 Global Cancer Targeted Drug Growth Trends by Region
2.2.1 Cancer Targeted Drug Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Cancer Targeted Drug Historic Market Size by Region (2018-2024)
2.2.3 Cancer Targeted Drug Forecasted Market Size by Region (2024-2029)
2.3 Cancer Targeted Drug Market Dynamics
2.3.1 Cancer Targeted Drug Industry Trends
2.3.2 Cancer Targeted Drug Market Drivers
2.3.3 Cancer Targeted Drug Market Challenges
2.3.4 Cancer Targeted Drug Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Cancer Targeted Drug by Players
3.1.1 Global Cancer Targeted Drug Revenue by Players (2018-2024)
3.1.2 Global Cancer Targeted Drug Revenue Market Share by Players (2018-2024)
3.2 Global Cancer Targeted Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Cancer Targeted Drug, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Cancer Targeted Drug Market Concentration Ratio
3.4.1 Global Cancer Targeted Drug Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cancer Targeted Drug Revenue in 2022
3.5 Global Key Players of Cancer Targeted Drug Head office and Area Served
3.6 Global Key Players of Cancer Targeted Drug, Product and Application
3.7 Global Key Players of Cancer Targeted Drug, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cancer Targeted Drug Breakdown Data by Type
4.1 Global Cancer Targeted Drug Historic Market Size by Type (2018-2024)
4.2 Global Cancer Targeted Drug Forecasted Market Size by Type (2024-2029)
5 Cancer Targeted Drug Breakdown Data by Application
5.1 Global Cancer Targeted Drug Historic Market Size by Application (2018-2024)
5.2 Global Cancer Targeted Drug Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Cancer Targeted Drug Market Size (2018-2029)
6.2 North America Cancer Targeted Drug Market Size by Type
6.2.1 North America Cancer Targeted Drug Market Size by Type (2018-2024)
6.2.2 North America Cancer Targeted Drug Market Size by Type (2024-2029)
6.2.3 North America Cancer Targeted Drug Market Share by Type (2018-2029)
6.3 North America Cancer Targeted Drug Market Size by Application
6.3.1 North America Cancer Targeted Drug Market Size by Application (2018-2024)
6.3.2 North America Cancer Targeted Drug Market Size by Application (2024-2029)
6.3.3 North America Cancer Targeted Drug Market Share by Application (2018-2029)
6.4 North America Cancer Targeted Drug Market Size by Country
6.4.1 North America Cancer Targeted Drug Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Cancer Targeted Drug Market Size by Country (2018-2024)
6.4.3 North America Cancer Targeted Drug Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Cancer Targeted Drug Market Size (2018-2029)
7.2 Europe Cancer Targeted Drug Market Size by Type
7.2.1 Europe Cancer Targeted Drug Market Size by Type (2018-2024)
7.2.2 Europe Cancer Targeted Drug Market Size by Type (2024-2029)
7.2.3 Europe Cancer Targeted Drug Market Share by Type (2018-2029)
7.3 Europe Cancer Targeted Drug Market Size by Application
7.3.1 Europe Cancer Targeted Drug Market Size by Application (2018-2024)
7.3.2 Europe Cancer Targeted Drug Market Size by Application (2024-2029)
7.3.3 Europe Cancer Targeted Drug Market Share by Application (2018-2029)
7.4 Europe Cancer Targeted Drug Market Size by Country
7.4.1 Europe Cancer Targeted Drug Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Cancer Targeted Drug Market Size by Country (2018-2024)
7.4.3 Europe Cancer Targeted Drug Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Cancer Targeted Drug Market Size (2018-2029)
8.2 China Cancer Targeted Drug Market Size by Type
8.2.1 China Cancer Targeted Drug Market Size by Type (2018-2024)
8.2.2 China Cancer Targeted Drug Market Size by Type (2024-2029)
8.2.3 China Cancer Targeted Drug Market Share by Type (2018-2029)
8.3 China Cancer Targeted Drug Market Size by Application
8.3.1 China Cancer Targeted Drug Market Size by Application (2018-2024)
8.3.2 China Cancer Targeted Drug Market Size by Application (2024-2029)
8.3.3 China Cancer Targeted Drug Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Cancer Targeted Drug Market Size (2018-2029)
9.2 Asia Cancer Targeted Drug Market Size by Type
9.2.1 Asia Cancer Targeted Drug Market Size by Type (2018-2024)
9.2.2 Asia Cancer Targeted Drug Market Size by Type (2024-2029)
9.2.3 Asia Cancer Targeted Drug Market Share by Type (2018-2029)
9.3 Asia Cancer Targeted Drug Market Size by Application
9.3.1 Asia Cancer Targeted Drug Market Size by Application (2018-2024)
9.3.2 Asia Cancer Targeted Drug Market Size by Application (2024-2029)
9.3.3 Asia Cancer Targeted Drug Market Share by Application (2018-2029)
9.4 Asia Cancer Targeted Drug Market Size by Region
9.4.1 Asia Cancer Targeted Drug Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Cancer Targeted Drug Market Size by Region (2018-2024)
9.4.3 Asia Cancer Targeted Drug Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Type
10.2.1 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Cancer Targeted Drug Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Application
10.3.1 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Cancer Targeted Drug Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Country
10.4.1 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Bayer
11.1.1 Bayer Company Details
11.1.2 Bayer Business Overview
11.1.3 Bayer Cancer Targeted Drug Introduction
11.1.4 Bayer Revenue in Cancer Targeted Drug Business (2018-2024)
11.1.5 Bayer Recent Developments
11.2 Eisai
11.2.1 Eisai Company Details
11.2.2 Eisai Business Overview
11.2.3 Eisai Cancer Targeted Drug Introduction
11.2.4 Eisai Revenue in Cancer Targeted Drug Business (2018-2024)
11.2.5 Eisai Recent Developments
11.3 Zelgen
11.3.1 Zelgen Company Details
11.3.2 Zelgen Business Overview
11.3.3 Zelgen Cancer Targeted Drug Introduction
11.3.4 Zelgen Revenue in Cancer Targeted Drug Business (2018-2024)
11.3.5 Zelgen Recent Developments
11.4 Cipla
11.4.1 Cipla Company Details
11.4.2 Cipla Business Overview
11.4.3 Cipla Cancer Targeted Drug Introduction
11.4.4 Cipla Revenue in Cancer Targeted Drug Business (2018-2024)
11.4.5 Cipla Recent Developments
11.5 Natco Pharma
11.5.1 Natco Pharma Company Details
11.5.2 Natco Pharma Business Overview
11.5.3 Natco Pharma Cancer Targeted Drug Introduction
11.5.4 Natco Pharma Revenue in Cancer Targeted Drug Business (2018-2024)
11.5.5 Natco Pharma Recent Developments
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Cancer Targeted Drug Introduction
11.6.4 AstraZeneca Revenue in Cancer Targeted Drug Business (2018-2024)
11.6.5 AstraZeneca Recent Developments
11.7 Novartis
11.7.1 Novartis Company Details
11.7.2 Novartis Business Overview
11.7.3 Novartis Cancer Targeted Drug Introduction
11.7.4 Novartis Revenue in Cancer Targeted Drug Business (2018-2024)
11.7.5 Novartis Recent Developments
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Cancer Targeted Drug Introduction
11.8.4 Roche Revenue in Cancer Targeted Drug Business (2018-2024)
11.8.5 Roche Recent Developments
11.9 Bristol-Myers Squibb
11.9.1 Bristol-Myers Squibb Company Details
11.9.2 Bristol-Myers Squibb Business Overview
11.9.3 Bristol-Myers Squibb Cancer Targeted Drug Introduction
11.9.4 Bristol-Myers Squibb Revenue in Cancer Targeted Drug Business (2018-2024)
11.9.5 Bristol-Myers Squibb Recent Developments
11.10 Pfizer
11.10.1 Pfizer Company Details
11.10.2 Pfizer Business Overview
11.10.3 Pfizer Cancer Targeted Drug Introduction
11.10.4 Pfizer Revenue in Cancer Targeted Drug Business (2018-2024)
11.10.5 Pfizer Recent Developments
11.11 BEACON Pharma
11.11.1 BEACON Pharma Company Details
11.11.2 BEACON Pharma Business Overview
11.11.3 BEACON Pharma Cancer Targeted Drug Introduction
11.11.4 BEACON Pharma Revenue in Cancer Targeted Drug Business (2018-2024)
11.11.5 BEACON Pharma Recent Developments
11.12 Jiangxi Shanxiang
11.12.1 Jiangxi Shanxiang Company Details
11.12.2 Jiangxi Shanxiang Business Overview
11.12.3 Jiangxi Shanxiang Cancer Targeted Drug Introduction
11.12.4 Jiangxi Shanxiang Revenue in Cancer Targeted Drug Business (2018-2024)
11.12.5 Jiangxi Shanxiang Recent Developments
11.13 Yao Pharma
11.13.1 Yao Pharma Company Details
11.13.2 Yao Pharma Business Overview
11.13.3 Yao Pharma Cancer Targeted Drug Introduction
11.13.4 Yao Pharma Revenue in Cancer Targeted Drug Business (2018-2024)
11.13.5 Yao Pharma Recent Developments
11.14 CSPC
11.14.1 CSPC Company Details
11.14.2 CSPC Business Overview
11.14.3 CSPC Cancer Targeted Drug Introduction
11.14.4 CSPC Revenue in Cancer Targeted Drug Business (2018-2024)
11.14.5 CSPC Recent Developments
11.15 CHIATAI Tianqing
11.15.1 CHIATAI Tianqing Company Details
11.15.2 CHIATAI Tianqing Business Overview
11.15.3 CHIATAI Tianqing Cancer Targeted Drug Introduction
11.15.4 CHIATAI Tianqing Revenue in Cancer Targeted Drug Business (2018-2024)
11.15.5 CHIATAI Tianqing Recent Developments
11.16 Simcere
11.16.1 Simcere Company Details
11.16.2 Simcere Business Overview
11.16.3 Simcere Cancer Targeted Drug Introduction
11.16.4 Simcere Revenue in Cancer Targeted Drug Business (2018-2024)
11.16.5 Simcere Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Cancer Targeted Drug Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Sorafenib
Table 3. Key Players of Lenvatinib
Table 4. Key Players of Regorafenib
Table 5. Key Players of Osimertinib
Table 6. Key Players of Anlotinib
Table 7. Key Players of Alectinib
Table 8. Key Players of Other
Table 9. Global Cancer Targeted Drug Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 10. Global Cancer Targeted Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 11. Global Cancer Targeted Drug Market Size by Region (2018-2024) & (US$ Million)
Table 12. Global Cancer Targeted Drug Market Share by Region (2018-2024)
Table 13. Global Cancer Targeted Drug Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 14. Global Cancer Targeted Drug Market Share by Region (2024-2029)
Table 15. Cancer Targeted Drug Market Trends
Table 16. Cancer Targeted Drug Market Drivers
Table 17. Cancer Targeted Drug Market Challenges
Table 18. Cancer Targeted Drug Market Restraints
Table 19. Global Cancer Targeted Drug Revenue by Players (2018-2024) & (US$ Million)
Table 20. Global Cancer Targeted Drug Revenue Share by Players (2018-2024)
Table 21. Global Top Cancer Targeted Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Targeted Drug as of 2022)
Table 22. Global Cancer Targeted Drug Industry Ranking 2021 VS 2022 VS 2024
Table 23. Global 5 Largest Players Market Share by Cancer Targeted Drug Revenue (CR5 and HHI) & (2018-2024)
Table 24. Global Key Players of Cancer Targeted Drug, Headquarters and Area Served
Table 25. Global Key Players of Cancer Targeted Drug, Product and Application
Table 26. Global Key Players of Cancer Targeted Drug, Product and Application
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Cancer Targeted Drug Market Size by Type (2018-2024) & (US$ Million)
Table 29. Global Cancer Targeted Drug Revenue Market Share by Type (2018-2024)
Table 30. Global Cancer Targeted Drug Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 31. Global Cancer Targeted Drug Revenue Market Share by Type (2024-2029)
Table 32. Global Cancer Targeted Drug Market Size by Application (2018-2024) & (US$ Million)
Table 33. Global Cancer Targeted Drug Revenue Share by Application (2018-2024)
Table 34. Global Cancer Targeted Drug Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 35. Global Cancer Targeted Drug Revenue Share by Application (2024-2029)
Table 36. North America Cancer Targeted Drug Market Size by Type (2018-2024) & (US$ Million)
Table 37. North America Cancer Targeted Drug Market Size by Type (2024-2029) & (US$ Million)
Table 38. North America Cancer Targeted Drug Market Size by Application (2018-2024) & (US$ Million)
Table 39. North America Cancer Targeted Drug Market Size by Application (2024-2029) & (US$ Million)
Table 40. North America Cancer Targeted Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. North America Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 42. North America Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 43. Europe Cancer Targeted Drug Market Size by Type (2018-2024) & (US$ Million)
Table 44. Europe Cancer Targeted Drug Market Size by Type (2024-2029) & (US$ Million)
Table 45. Europe Cancer Targeted Drug Market Size by Application (2018-2024) & (US$ Million)
Table 46. Europe Cancer Targeted Drug Market Size by Application (2024-2029) & (US$ Million)
Table 47. Europe Cancer Targeted Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 48. Europe Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 49. Europe Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 50. China Cancer Targeted Drug Market Size by Type (2018-2024) & (US$ Million)
Table 51. China Cancer Targeted Drug Market Size by Type (2024-2029) & (US$ Million)
Table 52. China Cancer Targeted Drug Market Size by Application (2018-2024) & (US$ Million)
Table 53. China Cancer Targeted Drug Market Size by Application (2024-2029) & (US$ Million)
Table 54. Asia Cancer Targeted Drug Market Size by Type (2018-2024) & (US$ Million)
Table 55. Asia Cancer Targeted Drug Market Size by Type (2024-2029) & (US$ Million)
Table 56. Asia Cancer Targeted Drug Market Size by Application (2018-2024) & (US$ Million)
Table 57. Asia Cancer Targeted Drug Market Size by Application (2024-2029) & (US$ Million)
Table 58. Asia Cancer Targeted Drug Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 59. Asia Cancer Targeted Drug Market Size by Region (2018-2024) & (US$ Million)
Table 60. Asia Cancer Targeted Drug Market Size by Region (2024-2029) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Type (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Type (2024-2029) & (US$ Million)
Table 63. Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Application (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Application (2024-2029) & (US$ Million)
Table 65. Middle East, Africa, and Latin America Cancer Targeted Drug Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 66. Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Country (2018-2024) & (US$ Million)
Table 67. Middle East, Africa, and Latin America Cancer Targeted Drug Market Size by Country (2024-2029) & (US$ Million)
Table 68. Bayer Company Details
Table 69. Bayer Business Overview
Table 70. Bayer Cancer Targeted Drug Product
Table 71. Bayer Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 72. Bayer Recent Developments
Table 73. Eisai Company Details
Table 74. Eisai Business Overview
Table 75. Eisai Cancer Targeted Drug Product
Table 76. Eisai Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 77. Eisai Recent Developments
Table 78. Zelgen Company Details
Table 79. Zelgen Business Overview
Table 80. Zelgen Cancer Targeted Drug Product
Table 81. Zelgen Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 82. Zelgen Recent Developments
Table 83. Cipla Company Details
Table 84. Cipla Business Overview
Table 85. Cipla Cancer Targeted Drug Product
Table 86. Cipla Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 87. Cipla Recent Developments
Table 88. Natco Pharma Company Details
Table 89. Natco Pharma Business Overview
Table 90. Natco Pharma Cancer Targeted Drug Product
Table 91. Natco Pharma Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 92. Natco Pharma Recent Developments
Table 93. AstraZeneca Company Details
Table 94. AstraZeneca Business Overview
Table 95. AstraZeneca Cancer Targeted Drug Product
Table 96. AstraZeneca Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 97. AstraZeneca Recent Developments
Table 98. Novartis Company Details
Table 99. Novartis Business Overview
Table 100. Novartis Cancer Targeted Drug Product
Table 101. Novartis Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 102. Novartis Recent Developments
Table 103. Roche Company Details
Table 104. Roche Business Overview
Table 105. Roche Cancer Targeted Drug Product
Table 106. Roche Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 107. Roche Recent Developments
Table 108. Bristol-Myers Squibb Company Details
Table 109. Bristol-Myers Squibb Business Overview
Table 110. Bristol-Myers Squibb Cancer Targeted Drug Product
Table 111. Bristol-Myers Squibb Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 112. Bristol-Myers Squibb Recent Developments
Table 113. Pfizer Company Details
Table 114. Pfizer Business Overview
Table 115. Pfizer Cancer Targeted Drug Product
Table 116. Pfizer Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 117. Pfizer Recent Developments
Table 118. BEACON Pharma Company Details
Table 119. BEACON Pharma Business Overview
Table 120. BEACON Pharma Cancer Targeted Drug Product
Table 121. BEACON Pharma Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 122. BEACON Pharma Recent Developments
Table 123. Jiangxi Shanxiang Company Details
Table 124. Jiangxi Shanxiang Business Overview
Table 125. Jiangxi Shanxiang Cancer Targeted Drug Product
Table 126. Jiangxi Shanxiang Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 127. Jiangxi Shanxiang Recent Developments
Table 128. Yao Pharma Company Details
Table 129. Yao Pharma Business Overview
Table 130. Yao Pharma Cancer Targeted Drug Product
Table 131. Yao Pharma Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 132. Yao Pharma Recent Developments
Table 133. CSPC Company Details
Table 134. CSPC Business Overview
Table 135. CSPC Cancer Targeted Drug Product
Table 136. CSPC Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 137. CSPC Recent Developments
Table 138. CHIATAI Tianqing Company Details
Table 139. CHIATAI Tianqing Business Overview
Table 140. CHIATAI Tianqing Cancer Targeted Drug Product
Table 141. CHIATAI Tianqing Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 142. CHIATAI Tianqing Recent Developments
Table 143. Simcere Company Details
Table 144. Simcere Business Overview
Table 145. Simcere Cancer Targeted Drug Product
Table 146. Simcere Revenue in Cancer Targeted Drug Business (2018-2024) & (US$ Million)
Table 147. Simcere Recent Developments
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Cancer Targeted Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Cancer Targeted Drug Market Share by Type: 2022 VS 2029
Figure 3. Sorafenib Features
Figure 4. Lenvatinib Features
Figure 5. Regorafenib Features
Figure 6. Osimertinib Features
Figure 7. Anlotinib Features
Figure 8. Alectinib Features
Figure 9. Other Features
Figure 10. Global Cancer Targeted Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 11. Global Cancer Targeted Drug Market Share by Application: 2022 VS 2029
Figure 12. Hospital Case Studies
Figure 13. Retail Pharmacy Case Studies
Figure 14. Other Case Studies
Figure 15. Cancer Targeted Drug Report Years Considered
Figure 16. Global Cancer Targeted Drug Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 17. Global Cancer Targeted Drug Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 18. Global Cancer Targeted Drug Market Share by Region: 2022 VS 2029
Figure 19. Global Cancer Targeted Drug Market Share by Players in 2022
Figure 20. Global Top Cancer Targeted Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cancer Targeted Drug as of 2022)
Figure 21. The Top 10 and 5 Players Market Share by Cancer Targeted Drug Revenue in 2022
Figure 22. North America Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. North America Cancer Targeted Drug Market Share by Type (2018-2029)
Figure 24. North America Cancer Targeted Drug Market Share by Application (2018-2029)
Figure 25. North America Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 26. United States Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Canada Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Europe Cancer Targeted Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 29. Europe Cancer Targeted Drug Market Share by Type (2018-2029)
Figure 30. Europe Cancer Targeted Drug Market Share by Application (2018-2029)
Figure 31. Europe Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 32. Germany Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. France Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. U.K. Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Italy Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Russia Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Nordic Countries Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. China Cancer Targeted Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 39. China Cancer Targeted Drug Market Share by Type (2018-2029)
Figure 40. China Cancer Targeted Drug Market Share by Application (2018-2029)
Figure 41. Asia Cancer Targeted Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 42. Asia Cancer Targeted Drug Market Share by Type (2018-2029)
Figure 43. Asia Cancer Targeted Drug Market Share by Application (2018-2029)
Figure 44. Asia Cancer Targeted Drug Market Share by Region (2018-2029)
Figure 45. Japan Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. South Korea Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 47. China Taiwan Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 48. Southeast Asia Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 49. India Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 50. Australia Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Middle East, Africa, and Latin America Cancer Targeted Drug Market Size YoY (2018-2029) & (US$ Million)
Figure 52. Middle East, Africa, and Latin America Cancer Targeted Drug Market Share by Type (2018-2029)
Figure 53. Middle East, Africa, and Latin America Cancer Targeted Drug Market Share by Application (2018-2029)
Figure 54. Middle East, Africa, and Latin America Cancer Targeted Drug Market Share by Country (2018-2029)
Figure 55. Brazil Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. Mexico Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 57. Turkey Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 58. Saudi Arabia Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 59. Israel Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 60. GCC Countries Cancer Targeted Drug Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 61. Bayer Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 62. Eisai Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 63. Zelgen Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 64. Cipla Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 65. Natco Pharma Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 66. AstraZeneca Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 67. Novartis Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 68. Roche Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 70. Pfizer Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 71. BEACON Pharma Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 72. Jiangxi Shanxiang Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 73. Yao Pharma Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 74. CSPC Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 75. CHIATAI Tianqing Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 76. Simcere Revenue Growth Rate in Cancer Targeted Drug Business (2018-2024)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries